USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Jul 26, 2022 | Jun 2022 | $0.16 | - | $0.53 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Jul 26, 2022 | Jun 2022 | $522.39M | - | $501.69M |
Biomarin Pharmaceutical's next earnings date is Tuesday, Jul 26, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 14 | $0.16 | $-0.03 | $0.57 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 17 | $0.73 | $-0.22 | $2.57 |
| Dec 2023 | 18 | $2.75 | $0.12 | $7.12 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 1 / 0 | $0.19 | $0.03 | $0.00 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 2 / 0 | $0.87 | $0.54 | $0.44 |
| Dec 2023 | 1 / 0 | $2.89 | $2.41 | $2.41 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 16 | $522.39M | $494.82M | $554.20M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 20 | $2.10B | $1.92B | $2.26B |
| Dec 2023 | 21 | $2.80B | $2.21B | $3.89B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Apr 27, 2022 | Mar 2022 | $0.17 | - | - |
| Feb 23, 2022 | Dec 2021 | $-0.32 | $-0.32 | - |
| Oct 27, 2021 | Sep 2021 | $0.09 | $0.18 | 104.93% |
| Jul 28, 2021 | Jun 2021 | $0.25 | $0.53 | 107.64% |
| Apr 29, 2021 | Mar 2021 | $0.30 | $0.57 | 86.84% |
| Feb 25, 2021 | Dec 2020 | $0.18 | $0.21 | 15.98% |
| Nov 5, 2020 | Sep 2020 | $0.26 | $0.50 | 95.73% |
| Aug 4, 2020 | Jun 2020 | $0.20 | $0.32 | 62.79% |
| Apr 29, 2020 | Mar 2020 | $0.33 | $0.62 | 86.27% |
| Feb 26, 2020 | Dec 2019 | $0.24 | $0.25 | 5.60% |
| Oct 23, 2019 | Sep 2019 | $0.34 | $0.42 | 23.23% |
| Aug 1, 2019 | Jun 2019 | $0.19 | $0.10 | -50.47% |
| Apr 25, 2019 | Mar 2019 | $0.10 | $0.14 | 35.71% |
| Feb 21, 2019 | Dec 2018 | $0.12 | $-0.06 | -152.42% |
| Oct 25, 2018 | Sep 2018 | $0.15 | $0.34 | 128.46% |
| Aug 2, 2018 | Jun 2018 | $0.15 | $0.11 | -24.90% |
| Apr 25, 2018 | Mar 2018 | $0.13 | $0.12 | -3.67% |
| Feb 22, 2018 | Dec 2017 | $0.04 | $0.03 | -23.12% |
| Oct 26, 2017 | Sep 2017 | $0.08 | $0.04 | -40.82% |
| Aug 2, 2017 | Jun 2017 | $0.08 | $0.15 | 82.42% |
| May 4, 2017 | Mar 2017 | $-0.01 | $0.20 | 1766.67% |
| Feb 23, 2017 | Dec 2016 | $-0.08 | $-0.16 | -109.33% |
| Oct 27, 2016 | Sep 2016 | $-0.08 | $0.02 | 121.28% |
| Aug 4, 2016 | Jun 2016 | $-0.11 | $0.10 | 190.99% |
| Apr 28, 2016 | Mar 2016 | $-0.28 | $-0.16 | 43.96% |
| Feb 25, 2016 | Dec 2015 | $-0.16 | $-0.43 | -173.38% |
| Oct 29, 2015 | Sep 2015 | $-0.65 | $-0.57 | 12.31% |
| Aug 3, 2015 | Jun 2015 | $-0.53 | $-0.51 | 3.77% |
| Apr 30, 2015 | Mar 2015 | $-0.53 | $-0.43 | 18.87% |
| Feb 25, 2015 | Dec 2014 | $-0.59 | $-0.47 | 20.34% |
| Oct 23, 2014 | Sep 2014 | $-0.23 | $0.05 | 121.74% |
| Jul 30, 2014 | Jun 2014 | $-0.42 | $-0.22 | 47.62% |
| May 1, 2014 | Mar 2014 | $-0.46 | $-0.33 | 28.26% |
| Feb 26, 2014 | Dec 2013 | $-0.35 | $-0.43 | -22.86% |
| Oct 24, 2013 | Sep 2013 | $-0.30 | $-0.38 | -26.67% |
| Jul 25, 2013 | Jun 2013 | $-0.29 | $-0.15 | 48.28% |
| Apr 25, 2013 | Mar 2013 | $-0.29 | $-0.31 | -6.90% |
| Feb 21, 2013 | Dec 2012 | $-0.27 | $-0.43 | -59.26% |
| Oct 25, 2012 | Sep 2012 | $-0.20 | $-0.04 | 80.00% |
| Aug 1, 2012 | Jun 2012 | $-0.21 | $-0.27 | -28.57% |
| Apr 26, 2012 | Mar 2012 | $-0.14 | $-0.21 | -50.00% |
| Feb 16, 2012 | Dec 2011 | $-0.11 | $-0.23 | -109.09% |
| Oct 27, 2011 | Sep 2011 | $-0.11 | $-0.14 | -27.27% |
| Jul 28, 2011 | Jun 2011 | $-0.11 | $-0.05 | 54.55% |
| Apr 28, 2011 | Mar 2011 | $-0.10 | $-0.04 | 60.00% |
| Feb 17, 2011 | Dec 2010 | $-0.02 | $0.01 | 150.00% |
| Oct 28, 2010 | Sep 2010 | $-0.01 | $1.68 | 16900.00% |
| Aug 2, 2010 | Jun 2010 | $0.03 | $-0.01 | -133.33% |
| Apr 29, 2010 | Mar 2010 | - | $0.01 | - |
| Feb 23, 2010 | Dec 2009 | $0.01 | $0.05 | 400.00% |
| Oct 28, 2009 | Sep 2009 | $0.01 | $0.06 | 500.00% |
| Jul 30, 2009 | Jun 2009 | $-0.01 | $0.01 | 200.00% |
| Apr 30, 2009 | Mar 2009 | $-0.12 | $-0.13 | -8.33% |
| Feb 18, 2009 | Dec 2008 | $0.26 | $0.21 | -19.23% |
| Oct 28, 2008 | Sep 2008 | $0.03 | $0.01 | -66.67% |
| Aug 5, 2008 | Jun 2008 | $0.03 | $0.04 | 33.33% |
| Apr 29, 2008 | Mar 2008 | $-0.05 | $0.02 | 140.00% |
| Feb 26, 2008 | Dec 2007 | $0.04 | $0.03 | -25.00% |
| Nov 1, 2007 | Sep 2007 | $-0.10 | $-0.05 | 50.00% |
| Aug 7, 2007 | Jun 2007 | $-0.06 | $-0.04 | 33.33% |
| Apr 30, 2007 | Mar 2007 | $-0.11 | $-0.10 | 9.09% |
| Feb 20, 2007 | Dec 2006 | $-0.13 | $-0.11 | 15.38% |
| Nov 1, 2006 | Sep 2006 | $-0.13 | $-0.08 | 38.46% |
| Aug 2, 2006 | Jun 2006 | $-0.11 | $-0.02 | 81.82% |
| May 3, 2006 | Mar 2006 | $-0.21 | $-0.13 | 38.10% |
| Feb 23, 2006 | Dec 2005 | $-0.22 | $-0.20 | 9.09% |
| Nov 1, 2005 | Sep 2005 | $-0.28 | $-0.21 | 25.00% |
| Aug 1, 2005 | Jun 2005 | $-0.35 | $-0.33 | 5.71% |
| May 5, 2005 | Mar 2005 | $-0.35 | $-0.35 | - |
| Feb 23, 2005 | Dec 2004 | $-0.33 | $-0.23 | 30.30% |
| Nov 3, 2004 | Sep 2004 | $-0.36 | $-0.40 | -11.11% |
| Aug 9, 2004 | Jun 2004 | $-0.29 | $-0.28 | 3.45% |
| May 4, 2004 | Mar 2004 | $-0.31 | $-0.31 | - |
| Feb 3, 2004 | Dec 2003 | $-0.38 | $-0.40 | -5.26% |
| Nov 4, 2003 | Sep 2003 | $-0.39 | $-0.33 | 15.38% |
| Aug 5, 2003 | Jun 2003 | $-0.16 | $-0.14 | 12.50% |
| May 5, 2003 | Mar 2003 | $-0.28 | $-0.35 | -25.00% |
| Feb 9, 2003 | Dec 2002 | $-0.35 | $-0.36 | -2.86% |
| Oct 31, 2002 | Sep 2002 | $-0.31 | $-0.32 | -3.23% |
| Aug 1, 2002 | Jun 2002 | $-0.29 | $-0.27 | 6.90% |
| May 7, 2002 | Mar 2002 | $-0.33 | $-0.51 | -54.55% |
| Feb 25, 2002 | Dec 2001 | $-0.30 | $-0.34 | -13.33% |
| Oct 26, 2001 | Sep 2001 | $-0.30 | $-0.26 | 13.33% |
| Jul 27, 2001 | Jun 2001 | $-0.26 | $-0.30 | -15.38% |
| Apr 27, 2001 | Mar 2001 | $-0.26 | $-0.26 | - |
| Feb 22, 2001 | Dec 2000 | $-0.33 | $-0.28 | 15.15% |
| Oct 30, 2000 | Sep 2000 | $-0.29 | $-0.23 | 20.69% |
| Jul 28, 2000 | Jun 2000 | $-0.27 | $-0.19 | 29.63% |
| Apr 28, 2000 | Mar 2000 | $-0.26 | $-0.34 | -30.77% |
| Feb 18, 2000 | Dec 1999 | $-0.26 | $-0.26 | - |
| Nov 1, 1999 | Sep 1999 | $-0.22 | $-0.24 | -9.09% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $-0.37 | $0.96 | - |
| Feb 25, 2021 | Dec 2020 | $4.03 | $1.65 | -58.97% |
| Feb 26, 2020 | Dec 2019 | $-0.29 | $0.91 | - |
| Feb 21, 2019 | Dec 2018 | $-0.65 | $0.51 | - |
| Feb 22, 2018 | Dec 2017 | $-0.58 | $0.43 | - |
| Feb 23, 2017 | Dec 2016 | - | $-0.20 | - |
| Feb 25, 2016 | Dec 2015 | - | $-1.94 | - |
| Feb 25, 2015 | Dec 2014 | - | $-0.97 | - |
| Feb 26, 2014 | Dec 2013 | - | $-1.27 | - |
| Feb 21, 2013 | Dec 2012 | - | $-0.95 | - |
| Feb 16, 2012 | Dec 2011 | - | $-0.46 | - |
| Feb 17, 2011 | Dec 2010 | - | $1.69 | - |
| Feb 23, 2010 | Dec 2009 | - | $-0.01 | - |
| Feb 18, 2009 | Dec 2008 | - | $0.28 | - |
| Feb 26, 2008 | Dec 2007 | - | $-0.16 | - |
| Feb 20, 2007 | Dec 2006 | - | $-0.34 | - |
| Feb 23, 2006 | Dec 2005 | - | $-1.09 | - |
| Feb 23, 2005 | Dec 2004 | - | $-1.22 | - |
| Feb 3, 2004 | Dec 2003 | - | $-1.22 | - |
| Feb 9, 2003 | Dec 2002 | - | $-1.46 | - |
| Feb 25, 2002 | Dec 2001 | - | $-1.16 | - |
| Feb 22, 2001 | Dec 2000 | - | $-1.04 | - |
| Feb 18, 2000 | Dec 1999 | - | $-0.50 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Apr 27, 2022 | Mar 2022 | $509.40M | - | - |
| Feb 23, 2022 | Dec 2021 | $442.39M | $449.81M | 1.02% |
| Oct 27, 2021 | Sep 2021 | $436.53M | $408.74M | 0.94% |
| Jul 28, 2021 | Jun 2021 | $448.79M | $501.69M | 1.12% |
| Apr 29, 2021 | Mar 2021 | $446.45M | $486.07M | 1.09% |
| Feb 25, 2021 | Dec 2020 | $452.12M | $452.12M | 1.00% |
| Nov 5, 2020 | Sep 2020 | $454.64M | $476.78M | 1.05% |
| Aug 4, 2020 | Jun 2020 | $418.61M | $429.49M | 1.03% |
| Apr 29, 2020 | Mar 2020 | $468.77M | $502.07M | 1.07% |
| Feb 26, 2020 | Dec 2019 | $459.33M | $454.44M | 0.99% |
| Oct 23, 2019 | Sep 2019 | $454.55M | $461.10M | 1.01% |
| Aug 1, 2019 | Jun 2019 | $415.04M | $387.76M | 0.93% |
| Apr 25, 2019 | Mar 2019 | $389.69M | $400.75M | 1.03% |
| Feb 21, 2019 | Dec 2018 | $377.35M | $353.21M | 0.94% |
| Oct 25, 2018 | Sep 2018 | $367.09M | $391.71M | 1.07% |
| Aug 2, 2018 | Jun 2018 | $372.85M | $372.85M | 1.00% |
| Apr 25, 2018 | Mar 2018 | $348.57M | $373.45M | 1.07% |
| Feb 22, 2018 | Dec 2017 | $351.62M | $358.31M | 1.02% |
| Oct 26, 2017 | Sep 2017 | $351.78M | $334.15M | 0.95% |
| Aug 2, 2017 | Jun 2017 | $308.96M | $317.45M | 1.03% |
| May 4, 2017 | Mar 2017 | - | $303.75M | - |
| Feb 23, 2017 | Dec 2016 | - | $300.09M | - |
| Oct 27, 2016 | Sep 2016 | - | $279.90M | - |
| Aug 4, 2016 | Jun 2016 | - | $300.13M | - |
| Apr 28, 2016 | Mar 2016 | - | $236.74M | - |
| Feb 25, 2016 | Dec 2015 | - | $227.94M | - |
| Oct 29, 2015 | Sep 2015 | - | $208.90M | - |
| Aug 3, 2015 | Jun 2015 | - | $250.52M | - |
| Apr 30, 2015 | Mar 2015 | - | $203.26M | - |
| Feb 25, 2015 | Dec 2014 | - | $230.85M | - |
| Oct 23, 2014 | Sep 2014 | - | $176.85M | - |
| Jul 30, 2014 | Jun 2014 | - | $191.79M | - |
| May 1, 2014 | Mar 2014 | - | $151.55M | - |
| Feb 26, 2014 | Dec 2013 | - | $146.87M | - |
| Oct 24, 2013 | Sep 2013 | - | $136.87M | - |
| Jul 25, 2013 | Jun 2013 | - | $136.81M | - |
| Apr 25, 2013 | Mar 2013 | - | $127.93M | - |
| Feb 21, 2013 | Dec 2012 | - | $131.94M | - |
| Oct 25, 2012 | Sep 2012 | - | $128.12M | - |
| Aug 1, 2012 | Jun 2012 | - | $124.02M | - |
| Apr 26, 2012 | Mar 2012 | - | $116.65M | - |
| Feb 16, 2012 | Dec 2011 | - | $107.85M | - |
| Oct 27, 2011 | Sep 2011 | - | $113.42M | - |
| Jul 28, 2011 | Jun 2011 | - | $110.63M | - |
| Apr 28, 2011 | Mar 2011 | - | $109.46M | - |
| Feb 17, 2011 | Dec 2010 | - | $101.61M | - |
| Oct 28, 2010 | Sep 2010 | - | $97.75M | - |
| Aug 2, 2010 | Jun 2010 | - | $91.95M | - |
| Apr 29, 2010 | Mar 2010 | - | $84.95M | - |
| Feb 23, 2010 | Dec 2009 | - | $87.08M | - |
| Oct 28, 2009 | Sep 2009 | - | $80.81M | - |
| Jul 30, 2009 | Jun 2009 | - | $82.79M | - |
| Apr 30, 2009 | Mar 2009 | - | $73.98M | - |
| Feb 18, 2009 | Dec 2008 | - | $99.28M | - |
| Oct 28, 2008 | Sep 2008 | - | $72.65M | - |
| Aug 5, 2008 | Jun 2008 | - | $64.17M | - |
| Apr 29, 2008 | Mar 2008 | - | $60.40M | - |
| Feb 26, 2008 | Dec 2007 | - | $44.85M | - |
| Nov 1, 2007 | Sep 2007 | - | $25.01M | - |
| Aug 7, 2007 | Jun 2007 | - | $28.88M | - |
| Apr 30, 2007 | Mar 2007 | - | $22.84M | - |
| Feb 20, 2007 | Dec 2006 | - | $22.02M | - |
| Nov 1, 2006 | Sep 2006 | - | $24.93M | - |
| Aug 2, 2006 | Jun 2006 | - | $23.45M | - |
| May 3, 2006 | Mar 2006 | - | $13.81M | - |
| Feb 23, 2006 | Dec 2005 | - | $9.47M | - |
| Nov 1, 2005 | Sep 2005 | - | $7.58M | - |
| Aug 1, 2005 | Jun 2005 | - | $3.63M | - |
| May 5, 2005 | Mar 2005 | - | $4.99M | - |
| Feb 23, 2005 | Dec 2004 | - | $13.90M | - |
| Nov 3, 2004 | Sep 2004 | - | $181.00K | - |
| Aug 9, 2004 | Jun 2004 | - | $4.56M | - |
| May 4, 2004 | Mar 2004 | - | $0.00 | - |
| Feb 3, 2004 | Dec 2003 | - | $12.10M | - |
| Nov 4, 2003 | Sep 2003 | - | $12.10M | - |
| Aug 5, 2003 | Jun 2003 | - | $12.10M | - |
| May 5, 2003 | Mar 2003 | - | $3.50M | - |
| Feb 9, 2003 | Dec 2002 | - | $3.13M | - |
| Oct 31, 2002 | Sep 2002 | - | $3.57M | - |
| Aug 1, 2002 | Jun 2002 | - | $3.42M | - |
| May 7, 2002 | Mar 2002 | - | $3.79M | - |
| Feb 25, 2002 | Dec 2001 | - | $891.00K | - |
| Oct 26, 2001 | Sep 2001 | - | $3.74M | - |
| Jul 27, 2001 | Jun 2001 | - | $3.66M | - |
| Apr 27, 2001 | Mar 2001 | - | $3.40M | - |
| Feb 22, 2001 | Dec 2000 | - | $3.14M | - |
| Oct 30, 2000 | Sep 2000 | - | $2.81M | - |
| Jul 28, 2000 | Jun 2000 | - | $3.08M | - |
| Apr 28, 2000 | Mar 2000 | - | $3.30M | - |
| Feb 18, 2000 | Dec 1999 | - | $2.28M | - |
| Nov 1, 1999 | Sep 1999 | - | $2.00M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 23, 2022 | Dec 2021 | $1.84B | $1.85B | 0.35% |
| Feb 25, 2021 | Dec 2020 | $1.86B | $1.86B | 0.00% |
| Feb 26, 2020 | Dec 2019 | $1.71B | $1.70B | -0.22% |
| Feb 21, 2019 | Dec 2018 | $1.51B | $1.49B | -1.45% |
| Feb 22, 2018 | Dec 2017 | $1.30B | $1.31B | 0.75% |
| Feb 23, 2017 | Dec 2016 | - | $1.12B | - |
| Feb 25, 2016 | Dec 2015 | - | $889.89M | - |
| Feb 25, 2015 | Dec 2014 | - | $751.04M | - |
| Feb 26, 2014 | Dec 2013 | - | $548.49M | - |
| Feb 21, 2013 | Dec 2012 | - | $500.72M | - |
| Feb 16, 2012 | Dec 2011 | - | $441.36M | - |
| Feb 17, 2011 | Dec 2010 | - | $376.27M | - |
| Feb 23, 2010 | Dec 2009 | - | $324.66M | - |
| Feb 18, 2009 | Dec 2008 | - | $296.49M | - |
| Feb 26, 2008 | Dec 2007 | - | $121.58M | - |
| Feb 20, 2007 | Dec 2006 | - | $84.21M | - |
| Feb 23, 2006 | Dec 2005 | - | $25.67M | - |
| Feb 23, 2005 | Dec 2004 | - | $18.64M | - |
| Feb 3, 2004 | Dec 2003 | - | $12.10M | - |
| Feb 9, 2003 | Dec 2002 | - | $13.92M | - |
| Feb 25, 2002 | Dec 2001 | - | $11.70M | - |
| Feb 22, 2001 | Dec 2000 | - | $12.33M | - |
| Feb 18, 2000 | Dec 1999 | - | $6.98M | - |
BMRN's next earnings date is Tuesday, Jul 26, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Biomarin Pharmaceutical's next quarterly earnings is $0.16, with a low EPS estimation of $-0.03, and a high estimation of $0.57.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.19, the last 2 month trend is $0.03, and the 3 month trend is $0.00.
Based on analysts, the average revenue estimation is $522.39M, with a low revenue estimation of $494.82M, and a high estimation of $554.20M.
Biomarin Pharmaceutical's previous earnings date was Apr 27, 2022 for its fiscal quarter ended Mar 31, 2022.
Biomarin Pharmaceutical's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.
BMRN's earnings per share (EPS) was $0.96, beating the consensus analysts forecast of $-0.37 by -358.51% , and lower than the previous year's EPS (Dec 2020) by -42.15%.
Revenues were $1.85B, better than the forecast of $1.84B by 0.35%, and down by -0.76% from previous year's revenue.
The company reported a net income of $-64.08M.
Biomarin Pharmaceutical reported a free cash flow of $185.31M for its fiscal year, compared to $-52.15M a year ago.
The company ended the fiscal year with $1.09B in total debt, an increase of 0.24% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
